Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
Mastacouris N, Tannenbaum R, Strunk A, Koptyev J, Aarts P, Alhusayen R, Bechara FG, Benhadou F, Bettoli V, Brassard A, Brown D, Choon SE, Coutts P, da Silva DLF, Daveluy S, Dellavalle RP, Del Marmol V, Emtestam L, Gebauer K, George R, Giamarellos-Bourboulis EJ, Goldfarb N, Hamzavi I, Hazen PG, Horváth B, Hsiao J, Ingram JR, Jemec GBE, Kirby JS, Lowes MA, Marzano AV, Matusiak L, Naik HB, Okun MM, Oon HH, Orenstein LAV, Paek SY, Pascual JC, Fernandez-Peñas P, Resnik BI, Sayed CJ, Thorlacius L, van der Zee HH, van Straalen KR, Garg A. Mastacouris N, et al. Among authors: marzano av. JAMA Dermatol. 2023 Nov 1;159(11):1258-1266. doi: 10.1001/jamadermatol.2023.3282. JAMA Dermatol. 2023. PMID: 37755725
The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum.
Rick J, Gould LJ, Marzano AV, Garg A, Chen D, Oakes DL, Dissemond J, Herfarth H, Friedman MA, Alavi A, Yamamoto T, Gerbens LAA, Thomas KS, Ortega-Loayza AG. Rick J, et al. Among authors: marzano av. Arch Dermatol Res. 2023 May;315(4):983-988. doi: 10.1007/s00403-022-02424-1. Epub 2022 Oct 28. Arch Dermatol Res. 2023. PMID: 36305958
Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.
Williams JC, Alhusayen R, Guilbault S, Hills NK, Ingram JR, Kudlinski MV, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA, Naik HB. Williams JC, et al. Among authors: marzano av. Dermatology. 2023;239(2):283-286. doi: 10.1159/000527401. Epub 2022 Dec 23. Dermatology. 2023. PMID: 36566748 Free PMC article. No abstract available.
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.
Greenlund L, Herzog C, Wendland Z, Rypka K, Frew JW, Kirby JS, Alavi A, Khalid B, Lowes MA, Garg A, Marzano AV, Zouboulis CC, Tzellos T, Jaleel T, Goldfarb N. Greenlund L, et al. Among authors: marzano av. J Eur Acad Dermatol Venereol. 2024 Apr 10. doi: 10.1111/jdv.19999. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38595320
Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.
Meijer JM, Rashid H, Vergadi S, Antiga E, Vezzoli P, Balestri R, Patsatsi A, Uzun S, Skiljevic D, Jedlickova H, Janickova L, Corrà A, Ponziani A, Günther C, Cianchini G, Schefzyk M, Marzano A, Di Zenzo G, Shimanovich I, Fairley J, Mascaró JM Jr, Caproni M, Maglie R, Schmidt E, Horváth B. Meijer JM, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1189-e1191. doi: 10.1111/jdv.19242. Epub 2023 Jun 21. J Eur Acad Dermatol Venereol. 2023. PMID: 37291996 No abstract available.
A case of PASH syndrome treated with guselkumab.
Marletta DA, Barei F, Moltrasio C, Genovese G, Marzano AV. Marletta DA, et al. Among authors: marzano av. Int J Dermatol. 2023 Nov;62(11):e585-e587. doi: 10.1111/ijd.16766. Epub 2023 Jun 25. Int J Dermatol. 2023. PMID: 37356041 No abstract available.
A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG; UPGRADE. Jacobson ME, et al. Among authors: marzano av. Br J Dermatol. 2024 Feb 16;190(3):392-401. doi: 10.1093/bjd/ljad420. Br J Dermatol. 2024. PMID: 37952167 Review.
458 results